Integrating cancer and end-of-life care in Staffordshire

hands on a walking stick

09 / 09 / 2014


In Staffordshire, four clinical commissioning groups (CCGs), NHS England and Public Health England are working with Macmillan Cancer Support, and with the support of two local authorities, to redesign cancer and end-of-life care services. They are co-designing new care pathways with patients and carers.

How it works

Care is to be managed and contracted through a single provider, which will be held accountable for the entire patient experience and clinical outcomes. Providers will need to demonstrate they have achieved a pre-agreed set of quality measures within a given expenditure target. Involvement of service users and carers is central in determining the outcomes for this contract. The prime-provider contracts will replace around 70 separate sub-contracting arrangements. 

Contracts will be for ten years. In the first two years, the CCGs and Macmillan will support the selected prime providers to improve the currently available data on activity and costs, which is not yet sufficiently sophisticated to enable a purely outcomes-based approach as it is focused on interventions and individual providers, not on the whole pathway.

Therefore, a key element of the prime provider’s work in the first two years will be to improve the data and analytics in order to provide a basis for a truly outcomes-based contract. They will also be expected to demonstrate real improvement in patient and carer experience. During the first two years the contract will be fee based.

Contract responsibility will formally transfer to the prime providers in the third year when the data is robust enough for effective pathway-outcomes performance management. This may then allow for risk and gain share. The prime provider could potentially not be a provider of any of the clinical services involved but rather focus solely on the job of integrator, sub-contracting all service delivery.

Want to know more?

Latest Tweets

Latest Blog Post

Tackling medicines wastage through a scalable initiative | Diar Fattah

14 / 12 / 2018 12.08pm

With estimates exceeding £300 million wasted every year in the NHS on unused or partially used medicine, Diar Fattah, associate director of medicines optimisation at Dartford, Gravesham and Swanley (DGS) CCG, believes savings and efficiency opportunities around medicines wastage are ripe for the taking.

Why Register?

Great reasons to register with NHS Confederation

  • Access exclusive resources 
    Access member-only resources and tailor member benefits and services
  • Personalise your website
    Select topics of interest for recommended content
  • Comment and recommend
    Rate and share content with colleagues
  • Never miss a thing
    Register now to keep your finger on the pulse of the NHS Confederation

Log In

To book events and access member only content you need to register with us.  This only takes a moment via our registration page. If you have already registered login using your email address and password below.